TSX/BCT (TSX/BCT)

Toronto Stock Exchange: TSX/BCT · CAD

CA$4.75

-0.11 (-2.3%)· Recorded snapshot

Market cap	41.3M
Net income (ttm)	-49M
EPS (ttm)	-CA$9.77
Shares out	8.7M
Volume	6,426
Beta	1.51

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -49M
EPS (ttm): -CA$9.77
Market cap: 41.3M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 11P50 16.8P75 23.9

Trailing P/En/a

P25 9.9P50 23.3P75 38.5

ROE-214.8

P25 -104.1P50 -30P75 6.7

ROIC-137

P25 -55.9P50 -12.1P75 5

Benchmarks · 1M

All TSX/BCT indicators

Market & fundamental data

Available fields

159

Groups with data

Currency

USD

Showing 159 of 159 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-03
Employees	16
Employees change	10
Employees growth	166.67%
Enterprise value	CAD 11.3M
Exchange	Toronto Stock Exchange
Financial currency	USD
Financial report date	2026-07-31
First seen	2026-05-10
Fiscal year end	July
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CA10778Y3023
Last earnings date	2025-12-12
Last refreshed	2026-10-29
Last stock split date	2025-08-25
Last stock split type	Reverse
Market cap	CAD 41.3M
Next earnings date	2026-11-03
Price	CAD 4.75
Price currency	CAD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	tsx/BCT
Website	https://briacell.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-205.72%
FCF / EV yield	-328.65%
FCF yield	-95.49%
P/B ratio	1.94x
Price / tangible book value	1.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	CAD -3.1M
ROA	-99.64%
ROA (5Y)	-82%
ROCE	-231.15%
ROE	-214.79%
ROIC	-137.01%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	4
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -178,233
Depreciation and amortization	CAD 166,733
EBIT	CAD -50.6M
EBITDA	CAD -50.4M
EPS	CAD -9.77
FCF per share	CAD -4.64
Financing cash flow	CAD 44.6M
Free cash flow	CAD -40.4M
Free cash flow minus SBC	CAD -42.8M
Investing cash flow	CAD -5.3M
Net cash flow	CAD -899,763
Net income	CAD -49M
Operating cash flow minus SBC	CAD -42.6M
Operating income	CAD -50.6M
Stock-based compensation	CAD 2.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CAD 2.64
Debt / equity	0
Long-term assets	CAD 2.3M
Long-term liabilities	CAD 99,994
Net cash (debt)	CAD 28.8M
Net cash / market cap	68.15%
Net cash growth	14.97%
Net debt / equity	-1.32
Piotroski F-Score	1
Property, plant and equipment	CAD 446,826
Shareholders' equity	CAD 21.8M
Tangible book value	CAD 22.8M
Tangible book value per share	CAD 2.61
Total assets	CAD 33.1M
Total cash	CAD 28.8M
Total debt	CAD 0
Total liabilities	CAD 11.3M
WACC	12.53%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CAD 30.8M
Current liabilities	CAD 11.2M
Current ratio	2.76
Net working capital	CAD -9.1M
Quick ratio	2.76
Working capital	CAD 19.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1,084.29%
Shareholder yield	-1,084.29%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-99.95%
10Y return CAGR	-53.22%
10Y total return	-99.95%
150-day SMA	CAD 5.15
1D price change	-2.26%
1M price change	-17.1%
1M total return	-17.1%
1W price change	-6.5%
1W total return	-6.5%
1Y price change	-74.53%
1Y return CAGR	-74.55%
1Y total return	-74.53%
20-day SMA	CAD 5.24
200-day SMA	CAD 5.30
3M price change	-2.26%
3M total return	-2.26%
3Y price change	-99.39%
3Y return CAGR	-81.74%
3Y total return	-99.39%
50-day SMA	CAD 5.31
50-day SMA vs 200-day SMA	50over200
52-week high	CAD 18.48
52-week high date	2025-10-29
52-week low	CAD 3.68
52-week low date	2026-06-11
5Y price change	-99.67%
5Y return CAGR	-68.18%
5Y total return	-99.67%
6M price change	-13.95%
6M total return	-13.95%
All-time high	CAD 21,150.21
All-time high date	2016-03-29
All-time low	CAD 3.68
All-time low date	2026-06-11
Average true range (ATR)	CAD 0.26
Average volume	3.9K
Beta (1Y)	0.88
Beta (2Y)	1.61
Beta (5Y)	1.51
Change from 52-week high	-74.3%
Change from 52-week low	29.08%
Change from all-time high	-99.98%
Change from all-time low	29.08%
Change from open	-5.38%
Day's gap	3.29%
Dollar volume	CAD 30,524
High price	CAD 5.02
Low price	CAD 4.75
Monthly RSI	32.01
Open price	CAD 5.02
Position in 52-week range	0%
Previous close	CAD 4.86
Price vs 150-day SMA	-7.68%
Price vs 20-day SMA	-9.35%
Price vs 200-day SMA	-10.29%
Price vs 50-day SMA	-10.55%
Relative volume	1.67
RSI	39.27
Sharpe ratio	-0.6
Sharpe ratio (3Y)	-0.83
Sharpe ratio (5Y)	-0.53
Sortino ratio	-0.78
Sortino ratio (3Y)	-1.08
Sortino ratio (5Y)	-0.68
Volume	6.4K
Weekly RSI	40.37
YTD price change	-51.53%
YTD total return	-51.53%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7.9M
Shares change (QoQ)	13.3%
Shares change (YoY)	1,084.29%
Shares held by insiders	2.1%
Shares held by institutions	7.51%
Shares outstanding	8.7M

Deeper analysis on TSX/BCT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSX/BCT report

Is a complete TSX/BCT research report available?

No complete published report is available for tsx/BCT (TSX/BCT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSX/BCT (TSX/BCT)

Price

Financial snapshot

Fair-value bridge

Latest news · TSX/BCT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSX/BCT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSX/BCT

Frequently asked questions